SEC Form 4 · accession 0000899243-18-003155
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart J Collinson
Director · 10% Owner
Period of report
Feb 5, 2018
Accepted (ET)
Feb 7, 2018 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 5, 2018 | A | 3,813 | $1.7263 | A | 1,459,361 | D | |
| Common StockF3 | holding | — | — | — | 7,251,728 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Effective January 1, 2017, annual board and committee retainers payable to directors will be made in equivalent shares of the Issuer's common stock, on a quarterly basis.
- F2The number of shares issuable in lieu of cash retainers was determined using the closing price per share of Issuer common stock on February 2, 2018, or $1.7263.
- F3Consists of shares of held by Forward Ventures V, L.P., or Forward Ventures. Mr. Collinson is a managing member of Forward Ventures and has shared voting power over the shares of Common Stock beneficially owned by Forward Ventures. Mr. Collinson disclaims beneficial ownership of such securities, except to the extent, if any, of his pecuniary interest therein.